NIH-funded research NIH-funded research

Investigating how inflammation affects thinking in people with acute depression.

Official title: The role of inflammation in cognitive dysfunction in acute depression as determined by experimental inhibition of tumor necrosis factor-alphasignaling in a randomized controlled trial.

Funded at Massachusetts General Hospital · NIH-11021026 · Data updated 2026-11-12

This study is looking at how inflammation might affect thinking and memory in people who are feeling very depressed, and it will test whether blocking a specific inflammation signal can help improve their mental performance.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$197,605
NIH project number5K23MH132893-02
Project IDNIH-11021026 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with acute depression who are experiencing cognitive dysfunction.

Less likely to help

Patients with cognitive dysfunction not related to depression or those who do not meet the criteria for acute depression may not benefit from this research.

What this research studies

This research explores the connection between inflammation and cognitive dysfunction in individuals experiencing acute depression. By focusing on the role of tumor necrosis factor-alpha (TNF-α) signaling, the study aims to understand how inflammation may contribute to cognitive deficits, particularly in areas like psychomotor speed and executive function. Participants will be involved in a randomized controlled trial that examines the effects of inhibiting TNF-α signaling on cognitive performance during depressive episodes. The study seeks to provide insights that could lead to new treatment strategies for improving cognitive function in depressed patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that enhance cognitive function in patients suffering from acute depression.

How similar studies have gone: Previous research has indicated a potential link between inflammation and cognitive dysfunction in depression, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Mac Giollabhui, Naoise — Massachusetts General Hospital
  • Study coordinator: Mac Giollabhui, Naoise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.